JD Friedland has served as Executive Director, Innovations and Ventures at Cleveland Clinic Innovations since November 2024. JD joined Cleveland Clinic in May 2021 as Partner, focusing on medical device investments was promoted to Managing Director, Ventures in October 2022. JD serves on the Boards of Enspire DBS, Infuseon Therapeutics, Mitria Medical, Navigate CSI and XII Medical. Prior to joining Cleveland Clinic, JD served as Managing Director at Wombat Capital, a New York-based boutique M&A advisory firm focused on the life sciences industry. JD has also held senior positions at Rothschild, Laza...read more